BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37207656)

  • 1. Calreticulin exposure orchestrates innate immunosurveillance.
    Guilbaud E; Kroemer G; Galluzzi L
    Cancer Cell; 2023 Jun; 41(6):1014-1016. PubMed ID: 37207656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calreticulin and cancer.
    Fucikova J; Spisek R; Kroemer G; Galluzzi L
    Cell Res; 2021 Jan; 31(1):5-16. PubMed ID: 32733014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin arms NK cells against leukemia.
    Fucikova J; Kline JP; Galluzzi L; Spisek R
    Oncoimmunology; 2020; 9(1):1671763. PubMed ID: 32002282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted calreticulin mutants subvert anticancer immunosurveillance.
    Liu P; Zhao L; Kroemer G; Kepp O
    Oncoimmunology; 2020; 9(1):1708126. PubMed ID: 32002304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
    Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
    Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.
    Truxova I; Kasikova L; Salek C; Hensler M; Lysak D; Holicek P; Bilkova P; Holubova M; Chen X; Mikyskova R; Reinis M; Kovar M; Tomalova B; Kline JP; Galluzzi L; Spisek R; Fucikova J
    Haematologica; 2020 Jul; 105(7):1868-1878. PubMed ID: 31582537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.
    Mózes R; Gángó A; Sulák A; Vida L; Reiniger L; Timár B; Krenács T; Alizadeh H; Masszi T; Gaál-Weisinger J; Demeter J; Csomor J; Matolcsy A; Kajtár B; Bödör C
    Pathology; 2019 Apr; 51(3):301-307. PubMed ID: 30606612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis.
    Daitoku S; Takenaka K; Yamauchi T; Yurino A; Jinnouchi F; Nunomura T; Eto T; Kamimura T; Higuchi M; Harada N; Saito N; Miyamoto T; Iwasaki H; Akashi K
    Exp Hematol; 2016 Sep; 44(9):817-825.e3. PubMed ID: 27185380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stressed out: NKp46 binds ecto-calreticulin.
    Corvino D; Rommel D; Schneppenheim F; Bald T
    Immunol Cell Biol; 2023 Sep; 101(8):684-686. PubMed ID: 37226854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant specific anti calreticulin antibody (CAL2) immunohistochemistry as a screening test for calreticulin (CALR) mutation testing.
    Rahman K; Chandra D; Singh MK; Gupta R; Sharma A; Paul P; Kumar S; Sharma S; Nityanand S
    Int J Lab Hematol; 2020 Oct; 42(5):604-611. PubMed ID: 32463176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin surface presentation can promote quality control of hematopoietic stem cells.
    Galluzzi L; Kroemer G
    Trends Immunol; 2022 Dec; 43(12):950-952. PubMed ID: 36307308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations.
    Takei H; Edahiro Y; Mano S; Masubuchi N; Mizukami Y; Imai M; Morishita S; Misawa K; Ochiai T; Tsuneda S; Endo H; Nakamura S; Eto K; Ohsaka A; Araki M; Komatsu N
    Br J Haematol; 2018 Jun; 181(6):791-802. PubMed ID: 29741776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation sensitive gel electrophoresis for the detection of calreticulin mutations in BCR-ABL1-negative myeloproliferative neoplasms.
    Zakaria NA; Rosle NA; Siti Asmaa MJ; Aziee S; Haiyuni MY; Samat NA; Husin A; Hassan R; Ramli M; Mohamed Yusoff S; Ibrahim IK; Al-Jamal HAN; Johan MF
    Int J Lab Hematol; 2021 Dec; 43(6):1451-1457. PubMed ID: 34125992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms.
    Andrici J; Farzin M; Clarkson A; Sioson L; Sheen A; Watson N; Toon CW; Koleth M; Stevenson W; Gill AJ
    Pathology; 2016 Jun; 48(4):319-24. PubMed ID: 27114372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera.
    Falchi M; Varricchio L; Martelli F; Marra M; Picconi O; Tafuri A; Girelli G; Uversky VN; Migliaccio AR
    Exp Hematol; 2017 Jun; 50():53-76. PubMed ID: 28232234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calreticulin mutations in myeloproliferative neoplasms.
    Shide K
    Int Rev Cell Mol Biol; 2021; 365():179-226. PubMed ID: 34756244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression by Mutated Calreticulin Released from Malignant Cells.
    Liu P; Zhao L; Loos F; Marty C; Xie W; Martins I; Lachkar S; Qu B; Waeckel-Énée E; Plo I; Vainchenker W; Perez F; Rodriguez D; López-Otin C; van Endert P; Zitvogel L; Kepp O; Kroemer G
    Mol Cell; 2020 Feb; 77(4):748-760.e9. PubMed ID: 31785928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.
    Vannucchi AM; Rotunno G; Bartalucci N; Raugei G; Carrai V; Balliu M; Mannarelli C; Pacilli A; Calabresi L; Fjerza R; Pieri L; Bosi A; Manfredini R; Guglielmelli P
    Leukemia; 2014 Sep; 28(9):1811-8. PubMed ID: 24618731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations.
    Rattarittamrong E; Tantiworawit A; Kumpunya N; Wongtagan O; Tongphung R; Phusua A; Chai-Adisaksopha C; Hantrakool S; Rattanathammethee T; Norasetthada L; Charoenkwan P; Lekawanvijit S
    Hematology; 2018 Oct; 23(9):613-619. PubMed ID: 29521158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.
    Di Buduo CA; Abbonante V; Marty C; Moccia F; Rumi E; Pietra D; Soprano PM; Lim D; Cattaneo D; Iurlo A; Gianelli U; Barosi G; Rosti V; Plo I; Cazzola M; Balduini A
    Blood; 2020 Jan; 135(2):133-144. PubMed ID: 31697806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.